| # | Side effect | Count |
|---|---|---|
| 0 | DRUG INEFFECTIVE | 85 |
| 1 | NO ADVERSE EVENT | 60 |
| 2 | PAIN | 6 |
| 3 | RASH | 6 |
| 4 | THERAPEUTIC RESPONSE DECREASED | 6 |
| 5 | APPLICATION SITE PAIN | 5 |
| 6 | PRODUCT QUALITY ISSUE | 5 |
| 7 | SKIN BURNING SENSATION | 5 |
| 8 | BLISTER | 4 |
| 9 | PAIN IN EXTREMITY | 4 |
| # | Side effect | Count | Frequency |
|---|---|---|---|
| 0 | ADMINISTRATION SITE NERVE DAMAGE | 1 | 0.1111 |
| 1 | INAPPROPRIATE RELEASE OF PRODUCT FOR DISTRIBUTION | 1 | 0.0208 |
| 2 | IMMATURE GRANULOCYTE PERCENTAGE INCREASED | 1 | 0.0164 |
| 3 | BURN INFECTION | 1 | 0.0049 |
| 4 | MUSCLE HYPERTROPHY | 1 | 0.0028 |
| 5 | POST-ACUTE COVID-19 SYNDROME | 3 | 0.0024 |
| 6 | BURNS THIRD DEGREE | 2 | 0.0019 |
| 7 | HYPERCHLORAEMIA | 1 | 0.0016 |
| 8 | CHONDROCALCINOSIS | 1 | 0.0015 |
| 9 | MICROALBUMINURIA | 1 | 0.0013 |